Tanita Corp.

Tanita Corp. specialises in two primary categories of medical devices: bioelectrical body composition analysers and electronic infant scales. The bioelectrical analysers measure metrics like fat mass, muscle mass, and hydration levels using bioelectrical impedance technology, while the electronic infant scales provide precise weight measurements for clinical or home use. These devices are designed for both professional and consumer settings.

Tanita Corp. is headquartered in the United States, which means its devices are subject to FDA regulations. The company’s products are listed in the FDA’s 510(k) and Unique Device Identifier (UDI) registries, demonstrating compliance with US medical device authorisation requirements. The FDA classifies some of Tanita’s devices as Class I (generally low-risk) and others as Class II (requiring special controls to ensure safety and effectiveness).

Tanita Corp.’s devices are listed in the FDA’s 510(k) premarket notification registry and the UDI system. The 510(k) registry shows that these devices have been evaluated for substantial equivalence to a predicate device, while the UDI system ensures traceability and transparency in the supply chain. Both registries are critical for tracking compliance with US medical device authorisation standards.

Tanita Corp.’s devices are classified under two FDA categories: Class I and Class II. Class I devices, such as some bioelectrical analysers, are typically low-risk and subject to general controls. Class II devices, which may include more complex body composition monitors, require additional regulatory oversight, including special controls to ensure their safety and performance. The classification depends on factors like the device’s intended use, potential risks, and the level of regulation needed to mitigate those risks.

The FDA categorises medical devices based on their risk levels and intended use. Tanita’s bioelectrical body composition analysers may fall into different classes depending on their features and potential risks. For example, simpler models with minimal risk might qualify as Class I, while more advanced devices—such as those with additional diagnostic capabilities or higher complexity—could be classified as Class II. This distinction ensures appropriate regulatory scrutiny proportional to the device’s potential impact on patient safety.